Dedicated to your research needs.

Subscribe

Please enter subscribe form shortcode

At Anilocus Inc., a leading preclinical contract research organization (CRO), we understand the critical importance of accessibility for our partners in the pharmaceutical and medical device sectors. Our website is designed to be a valuable resource, providing detailed information on our research services and state-of-the-art laboratory equipment tailored for in vivo studies.

Our Commitment to Accessibility

In alignment with our mission to support scientific advancements, we incorporate accessibility into our core operations:

  • Accessibility is integrated into our mission statement.
  • We uphold accessibility standards within our internal policies.
  • Our procurement practices reflect our commitment to accessible solutions.
  • We ensure ongoing accessibility training for our team.
  • Specific accessibility targets and responsibilities are clearly delineated.
  • We employ rigorous accessibility quality assurance methods.

Conformance Status

The Web Content Accessibility Guidelines (WCAG) 2.1 AA level serve as a benchmark for ensuring our website is accessible to all, including individuals with disabilities. Currently, Anilocus is partially conformant with these guidelines. While most of the content meets the specified standards, some areas require further adjustment to fully comply with all accessibility requirements.

Invitation for Feedback

Your feedback is invaluable in helping us enhance our website’s accessibility. Please report any barriers you encounter or suggest improvements:

Contact Us for Accessibility Feedback

Technical Basis for Accessibility

Our website’s accessibility relies on the following technologies:

  • HTML
  • CSS
  • JavaScript

These are essential for maintaining compliance with established accessibility standards.

Addressing Limitations

Despite our vigilant efforts, some limitations exist. Known issues include:

User comments and uploaded images might not have suitable text alternatives immediately available.
We actively monitor and resolve such issues within two business days of identification. Please use the ‘Contact’ feature to alert us to any concerns.

Assessment Practices

Accessibility at Anilocus Inc. is regularly assessed through self-evaluations and external reviews, ensuring ongoing compliance and improvements.

Document Information

This Accessibility Statement was initially drafted on 11 July 2023 and last updated on 11 July 2024.